For the amplification of partial RdRp gene region, primer RdRpSeq-Fwd and RdRpSeq-Rev were employed [5] , while primer NSeq-Fwd and NSeq-Rev were used for amplification of partial N gene region [5] . The RT-PCR amplifications were performed by using MyTaq ™ One-Step RT-PCR Kit (Bioline USA), following the parameters: 45 °C for 20 min, polymerase activation at 95 °C for 1 min followed by 45 cycles at 95 °C for 15 seconds, 56 °C for 15 seconds and 72 °C for 30 seconds and terminal elongation at 72 °C for 2 min. For amplification of RdRp, second-round PCR reaction was performed with RdRpSeq-Fwd (similar to the first round) and RdRpSeq-Rnest primer by using MyFi ™ Mix Kit (Bioline, USA) according to the following parameters: 95 °C for 1 min, followed by 35 cycles at 95 °C for 15 seconds, 56 °C for 15 seconds, 72 °C for 20 seconds, and 2 min at 72 °C for terminal elongation [5] . The resulted amplicons were separated by gel electrophoresis, and the DNA fragments were excised, purified and subjected to sequencing in both directions. The obtained sequences were verified by basic local alignment search tool.
Introduction
Middle East respiratory syndrome coronavirus (MERS-CoV) is a new coronavirus which belongs to lineage C of the genus Betacoronavirus and was first isolated from a patient with severe respiratory disease and renal failure in 2012. As of 13 June 2014, a total of 697 laboratory-confirmed cases with 210 deaths have been reported worldwide [1] . All these cases were reported among people either from or have travelled from the Arab Peninsular.
Most people infected with MERS-CoV and developed severe respiratory illnesses with symptoms of fever, cough, and shortness of breath. About 30% of the cases have succumbed to their illness and majority of those who died had underlying medical condition such as diabetes, cancer, and chronic lung, heart and kidney disease [2] . 
Materials and methods

Nucleic acid extraction and PCR
Combination of throat and nasal swab specimens received by Institute for Medical Research on 15 April 2014 was subjected to viral RNA extraction by using QIAamp Viral RNA Mini Kit (Qiagen, Germany) following the manufacturer's instruction.
For screening, the extracted RNA was subjected to rRT-PCR targeting upE, ORF1b and ORF1a [4, 5] , which were optimized for SuperScript III Platinum One-Step RT-PCR System with Platinum Taq Polymerase (Invitrogen, USA). For confirmation, the RNA was subjected to RT-PCR targeting partial part of the RNA-dependent RNA polymerase (RdRp) and nucleocapsid (N) [5] , followed by amplification of complete N gene region designed for subsequent phylogenetic analysis (Table 1) . Table 1 Primers used for amplification and sequencing of the Malaysian case.
Primer names and sequences Position * For amplification and sequencing NF1: 5'-ATGGCATCCCCTGCTGCACCTCGT-3' 28561-28373 NR1: 5'-CATCTTATTTTTAGCAGCAGCAGCATCT-3'
29310-29283 For sequencing NF2: 5'-AGCCAAAAGTAATCACTAAGAAAGATGCT-3' 29261-29289 NR2: 5'-CTAATCAGTGTTAACATCAATCATTGGA-3' 29591-29564 N350R: 5'- TTAACAGCCCGGAATGGGAGTGCT-3' 28887-28910 Nucleotide analysis of the complete N gene region showed that Figure 1 . Maximum-likelihood analysis of N gene region was constructed by using the Tamura-Nei model. Each branch showed, in Figure 1 , the GenBank accession number followed by description of the sequence used.
It is noted that the nucleotide sequence from the Malaysian case is clustered together with human-derived MERS-CoV sequences isolated from human cases in 2014, among them are those reported in Greece and USA. The sequences of the camel-derived MERS-CoV group together in their own cluster, however, close to those of human-derived sequences isolated in 2014.
Discussion
The sequence analysis of N gene region from the first case of MERS-CoV in Malaysia was reported. Comparative analysis of the N gene region from the Malaysian case and camel-derived MERS- CoV sequence showed more than 99% identities. The finding is concerted with results of studies performed in dromedary camel from Qatar [8] , Saudi Arabia [9, 10] and Oman [11] , which showed that the camel-derived and human-derived MERS-CoV were highly similar yet distinct. This is also reflected in the phylogenetic analysis; the camel-derived and human-derived sequences were independently clustered.
Based on the travel history of the Malaysian case, the infection may be acquired after being exposed to infected camels, via patting the camel especially their nostril region and consuming the raw, unpasteurized camel milk [3] . Similar observation as the Malaysian case has been reported by Memish et al. [9] , which substantiate the cross-species transmission to humans, with the possibility of dromedary camels being the primary reservoir hosts of MERS-CoV [8] [9] [10] [11] . Juvenile camels may play a big role in the viral transmission, since the younger were shown to shed more virus compared to the old ones [9, 10, 12] . The transmission from camels to human was postulated to occur through very close contact with high infectious dose of virus via nasal route [11] . Other possible route of transmission is via consumption of raw milk from infected camels, which was supported by a report showing that MERS-CoV could survive slightly longer in raw camel milk in comparison to other species [13] .
MERS-CoV in human emerged only recently, although it has been shown to be circulating in camels since 1992 or even earlier [10] . Even though higher frequency of MERS-CoV infection was observed in the camels of the Arabian Peninsula, low number of infections was recorded in human. Thus, further study to determine the exact mode of transmission from camel-to-human and human-to-human is important to mitigate the spread of this virus.
